Back to search
FDAFDA · Food and drugs·Recall number D-0129-2021

FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Published December 23, 2020 · Recall initiated: November 30, 2020

Summary

FDA records drug Class II recall D-0129-2021, published December 23, 2020 and initiated November 30, 2020. Recalling firm: Advanced Nutriceuticals, LLC; Status: Ongoing; Reported quantity: 1 vial; Lot: Lot #1112202006, Exp 12/12/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Advanced Nutriceuticals, LLC
Distributor
CA, CO, FL, IN, KY, OH, TX
Lot
Lot #1112202006, Exp 12/12/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN recalled?

Yes. FDA published recall D-0129-2021 on December 23, 2020. Reported hazard: Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Letter